Cargando…
SETD6 regulates NF-κB signaling in urothelial cell survival: Implications for bladder cancer
Non-muscle invasive bladder cancer has a high recurrence rate of 45-70%, progressing to muscle invasive disease in about 15% of those patients over a 5-year period. Administration of the mycobacterium, Bacillus Calmette-Guerin (BCG) that induces local inflammation resulting in tumor remission in res...
Autores principales: | Mukherjee, Neelam, Cardenas, Eduardo, Bedolla, Roble, Ghosh, Rita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362471/ https://www.ncbi.nlm.nih.gov/pubmed/28122346 http://dx.doi.org/10.18632/oncotarget.14750 |
Ejemplares similares
-
SETD6 lysine methylation of RelA couples GLP activity at chromatin to tonic repression of NF-κB signaling
por: Levy, Dan, et al.
Publicado: (2010) -
Structural basis of SETD6-mediated regulation of the NF-kB network via methyl-lysine signaling
por: Chang, Yanqi, et al.
Publicado: (2011) -
Proteomic analysis of SETD6 interacting proteins
por: Cohn, Ofir, et al.
Publicado: (2016) -
RIPK4 promotes bladder urothelial carcinoma cell aggressiveness by upregulating VEGF-A through the NF-κB pathway
por: Liu, Jian-Ye, et al.
Publicado: (2018) -
Peptide inhibition of the SETD6 methyltransferase catalytic activity
por: Feldman, Michal, et al.
Publicado: (2017)